VCYT
Veracyte, Inc.
NASDAQ · USHealthcareBiotechnology
$57.26-3.16%
Price as of Jul 20, 2026
VCYT valuation
Veracyte, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 33.26x
- P/E 2026E
- 35.43x
- P/E 2027E
- 32.70x
- P/E 2028E
- 29.99x
- P/S forward
- 7.46x
Trailing multiples
- P/E TTM
- 51.70x
- PEG TTM
- 0.95x
- Price / book
- 3.40x
- Price / sales
- 8.43x
- Price / cash flow
- 27.50x
Enterprise value
- Enterprise value
- $4.2B
- EV / sales
- 7.70x
- EV / EBITDA
- 37.15x
- EV / EBIT
- 61.80x
- Market cap
- $4.6B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.